ETFs
G
GILD
Gilead Sciences Inc
129.16
-0.02-0.02%After Hours: 128.53 -0.63 -0.49%19:56 06/05 EDT
OPEN/PREV CLOSE121.79/121.48
TODAY RANGE121.79-127.37
VOL271
MARKET CAP156.28B
52 WEEK RANGE102.48-156.40
AVG VOL (3M)6.62M
% TURNOVER0.70%
TURNOVER--
P/E (TTM)17.12
% RANGE4.59%
EPS(TTM)7.35
P/E(FORWARD)-43.7049
P/B6.65
BVPS18.93
DIVIDEND3.280
P/S5.31
BETA--
DIV YIELD2.61%
FREE FLOAT MKT CAP156.07B
SHARES OUTSTANDING1.24B
NEXT EARNINGS08/05-08/10
FREE FLOAT1.24B
LOT SIZE1
EX-DATE06/15/2026
News
Press Releases
Financial Reports
Profile
TipRanks·33m ago
Gilead Sciences (GILD) Gets a Buy from Needham
Simply Wall St·12h ago
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones
Dow Jones·14h ago
Moderna Inc. Stock Rises 7.9%, Outperforms Peers
Seeking Alpha·16h ago
Kymera, Monte Rosa among gainers as Novartis inks deal for molecular glue drugs
Seeking Alpha·21h ago
Top 10 most oversold S&P 500 stocks
TipRanks·1d ago
Gilead Sciences (GILD) Gets a Buy from Bernstein
Benzinga·2d ago
Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial
Simply Wall St·2d ago
Gilead Balances Trodelvy Setback With Once Weekly HIV Progress
Seeking Alpha·2d ago
Nurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg Expansions
Same Industry
Name/Symbol
Change%
Price